GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

New study reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Here's what they found.

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

Hidden health benefits from weight-loss shots revealed - The study saw experts from Taiwan examine data on 60,000 people from ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks—and retain much of it even six months after stopping ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the changes were more pronounced in women, researchers reported at ENDO 2025.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.